Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat

Kellie McFarlin, Xiaohua Gao, Yong Bo Liu, Deborah S. Dulchavsky, David Kwon, Ali Syed Arbab, Mona Bansal, Yi Li, Michael Chopp, Scott A. Dulchavsky, Subhash C. Gautam

Research output: Contribution to journalArticle

178 Citations (Scopus)

Abstract

Bone marrow-derived mesenchymal stromal cells (BMSCs) are multipotential stem cells capable of differentiation into numerous cell types, including fibroblasts, cartilage, bone, muscle, and brain cells. BMSCs also secrete a large number of growth factors and cytokines that are critical to the repair of injured tissues. Because of the extraordinary plasticity and the ability of syngeneic or allogeneic BMSCs to secrete tissue-repair factors, we investigated the therapeutic efficacy of BMSCs for healing of fascial and cutaneous incisional wounds in Sprague-Dawley rats. Systemic administration of syngeneic BMSCs (2 × 106) once daily for 4 days or a single treatment with 5 × 106 BMSCs 24 hours after wounding significantly increased the wound bursting strength of fascial and cutaneous wounds on days 7 and 14 postwounding. Wound healing was also significantly improved following injection of BMSCs locally at the wound site. Furthermore, allogeneic BMSCs were as efficient as syngeneic BMSCs in promoting wound healing. Administration of BMSCs labeled with iron oxides/1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate fluorescent dye revealed that systemically administered BMSCs engraft to the wound. The increase in the tensile strength of wounds treated with BMSCs was associated with increased production of collagen in the wound. In addition, BMSC treatment caused more rapid histologic maturation of wounds compared with untreated wounds. These data suggest that cell therapy with BMSCs has the potential to augment healing of surgical and cutaneous wounds.

Original languageEnglish (US)
Pages (from-to)471-478
Number of pages8
JournalWound Repair and Regeneration
Volume14
Issue number4
DOIs
StatePublished - Jul 1 2006
Externally publishedYes

Fingerprint

Mesenchymal Stromal Cells
Wound Healing
Bone Marrow
Wounds and Injuries
Skin
Tensile Strength
Thromboplastin
Cell- and Tissue-Based Therapy
Fluorescent Dyes
Muscle Cells
Cartilage
Sprague Dawley Rats
Cell Differentiation
Intercellular Signaling Peptides and Proteins
Collagen
Stem Cells
Therapeutics
Fibroblasts

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. / McFarlin, Kellie; Gao, Xiaohua; Liu, Yong Bo; Dulchavsky, Deborah S.; Kwon, David; Arbab, Ali Syed; Bansal, Mona; Li, Yi; Chopp, Michael; Dulchavsky, Scott A.; Gautam, Subhash C.

In: Wound Repair and Regeneration, Vol. 14, No. 4, 01.07.2006, p. 471-478.

Research output: Contribution to journalArticle

McFarlin, K, Gao, X, Liu, YB, Dulchavsky, DS, Kwon, D, Arbab, AS, Bansal, M, Li, Y, Chopp, M, Dulchavsky, SA & Gautam, SC 2006, 'Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat', Wound Repair and Regeneration, vol. 14, no. 4, pp. 471-478. https://doi.org/10.1111/j.1743-6109.2006.00153.x
McFarlin, Kellie ; Gao, Xiaohua ; Liu, Yong Bo ; Dulchavsky, Deborah S. ; Kwon, David ; Arbab, Ali Syed ; Bansal, Mona ; Li, Yi ; Chopp, Michael ; Dulchavsky, Scott A. ; Gautam, Subhash C. / Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. In: Wound Repair and Regeneration. 2006 ; Vol. 14, No. 4. pp. 471-478.
@article{0760bcb74da74db7bd687a097d4b8b66,
title = "Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat",
abstract = "Bone marrow-derived mesenchymal stromal cells (BMSCs) are multipotential stem cells capable of differentiation into numerous cell types, including fibroblasts, cartilage, bone, muscle, and brain cells. BMSCs also secrete a large number of growth factors and cytokines that are critical to the repair of injured tissues. Because of the extraordinary plasticity and the ability of syngeneic or allogeneic BMSCs to secrete tissue-repair factors, we investigated the therapeutic efficacy of BMSCs for healing of fascial and cutaneous incisional wounds in Sprague-Dawley rats. Systemic administration of syngeneic BMSCs (2 × 106) once daily for 4 days or a single treatment with 5 × 106 BMSCs 24 hours after wounding significantly increased the wound bursting strength of fascial and cutaneous wounds on days 7 and 14 postwounding. Wound healing was also significantly improved following injection of BMSCs locally at the wound site. Furthermore, allogeneic BMSCs were as efficient as syngeneic BMSCs in promoting wound healing. Administration of BMSCs labeled with iron oxides/1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate fluorescent dye revealed that systemically administered BMSCs engraft to the wound. The increase in the tensile strength of wounds treated with BMSCs was associated with increased production of collagen in the wound. In addition, BMSC treatment caused more rapid histologic maturation of wounds compared with untreated wounds. These data suggest that cell therapy with BMSCs has the potential to augment healing of surgical and cutaneous wounds.",
author = "Kellie McFarlin and Xiaohua Gao and Liu, {Yong Bo} and Dulchavsky, {Deborah S.} and David Kwon and Arbab, {Ali Syed} and Mona Bansal and Yi Li and Michael Chopp and Dulchavsky, {Scott A.} and Gautam, {Subhash C.}",
year = "2006",
month = "7",
day = "1",
doi = "10.1111/j.1743-6109.2006.00153.x",
language = "English (US)",
volume = "14",
pages = "471--478",
journal = "Wound Repair and Regeneration",
issn = "1067-1927",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat

AU - McFarlin, Kellie

AU - Gao, Xiaohua

AU - Liu, Yong Bo

AU - Dulchavsky, Deborah S.

AU - Kwon, David

AU - Arbab, Ali Syed

AU - Bansal, Mona

AU - Li, Yi

AU - Chopp, Michael

AU - Dulchavsky, Scott A.

AU - Gautam, Subhash C.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Bone marrow-derived mesenchymal stromal cells (BMSCs) are multipotential stem cells capable of differentiation into numerous cell types, including fibroblasts, cartilage, bone, muscle, and brain cells. BMSCs also secrete a large number of growth factors and cytokines that are critical to the repair of injured tissues. Because of the extraordinary plasticity and the ability of syngeneic or allogeneic BMSCs to secrete tissue-repair factors, we investigated the therapeutic efficacy of BMSCs for healing of fascial and cutaneous incisional wounds in Sprague-Dawley rats. Systemic administration of syngeneic BMSCs (2 × 106) once daily for 4 days or a single treatment with 5 × 106 BMSCs 24 hours after wounding significantly increased the wound bursting strength of fascial and cutaneous wounds on days 7 and 14 postwounding. Wound healing was also significantly improved following injection of BMSCs locally at the wound site. Furthermore, allogeneic BMSCs were as efficient as syngeneic BMSCs in promoting wound healing. Administration of BMSCs labeled with iron oxides/1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate fluorescent dye revealed that systemically administered BMSCs engraft to the wound. The increase in the tensile strength of wounds treated with BMSCs was associated with increased production of collagen in the wound. In addition, BMSC treatment caused more rapid histologic maturation of wounds compared with untreated wounds. These data suggest that cell therapy with BMSCs has the potential to augment healing of surgical and cutaneous wounds.

AB - Bone marrow-derived mesenchymal stromal cells (BMSCs) are multipotential stem cells capable of differentiation into numerous cell types, including fibroblasts, cartilage, bone, muscle, and brain cells. BMSCs also secrete a large number of growth factors and cytokines that are critical to the repair of injured tissues. Because of the extraordinary plasticity and the ability of syngeneic or allogeneic BMSCs to secrete tissue-repair factors, we investigated the therapeutic efficacy of BMSCs for healing of fascial and cutaneous incisional wounds in Sprague-Dawley rats. Systemic administration of syngeneic BMSCs (2 × 106) once daily for 4 days or a single treatment with 5 × 106 BMSCs 24 hours after wounding significantly increased the wound bursting strength of fascial and cutaneous wounds on days 7 and 14 postwounding. Wound healing was also significantly improved following injection of BMSCs locally at the wound site. Furthermore, allogeneic BMSCs were as efficient as syngeneic BMSCs in promoting wound healing. Administration of BMSCs labeled with iron oxides/1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate fluorescent dye revealed that systemically administered BMSCs engraft to the wound. The increase in the tensile strength of wounds treated with BMSCs was associated with increased production of collagen in the wound. In addition, BMSC treatment caused more rapid histologic maturation of wounds compared with untreated wounds. These data suggest that cell therapy with BMSCs has the potential to augment healing of surgical and cutaneous wounds.

UR - http://www.scopus.com/inward/record.url?scp=33747607464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747607464&partnerID=8YFLogxK

U2 - 10.1111/j.1743-6109.2006.00153.x

DO - 10.1111/j.1743-6109.2006.00153.x

M3 - Article

VL - 14

SP - 471

EP - 478

JO - Wound Repair and Regeneration

JF - Wound Repair and Regeneration

SN - 1067-1927

IS - 4

ER -